| RELB antibodies | |
| This is a review about RELB antibodies, based on 6 published articles using RELB antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited RELB antibody. Information in this review (with links to publications) can be searched freely. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology RELB products
includes other brands or spellings
|
| chip, emsa, wb | | Santa Cruz Biotechnologies rabbit anti-Rel-B antibody was used in western blot, EMSA and ChIP assay to study the regulation of human 3' Igh hs4 enhancer activity in B cells by synergistic interaction between Oct-2 and NF-kappaB. |
| emsa | | Santa Cruz Biotechnology RelB antibody was used in EMSA to study RANTES expression regulation by plasma membrane CFTR. |
| emsa | | Santa Cruz Biotechnology anti-RelB antibody was used in EMSA to study the effect of mutated IκB kinase and IκBα on HAS1 activation. |
| ip, wb | | Santa Cruz Biotechnology anti-RelB antibody sc-226 was used in immunoprecipitation and western blot to study the role of RelB serine 368 for dimerization and p100 stabilization. |
| wb | | Santa Cruz Biotechnology antibody for RelB was used in western blot to study the function of an atypical TNFR-associated factor-binding motif of BAFFR to mediate induction of the noncanonical NF-kappaB signaling pathway. |
| wb | | Santa Cruz Biotechnology anti-RelB antibody was used in western blot to study the Rel family protein expression. |
Articles Reviewed |
| 1. Kaoru Saijo et al. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. 2002 |
| 2. Kim Estell et al. Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. 2003 |
| 3. Harald Jakob Maier et al. Critical role of RelB serine 368 for dimerization and p100 stabilization. 2003 |
| 4. Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 |
| 5. Matthew D Morrison et al. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. 2005 |
| 6. Karl M Stuhlmeier et al. Adenovirus-mediated gene transfer of mutated IkappaB kinase and IkappaBalpha reveal NF-kappaB-dependent as well as NF-kappaB-independent pathways of HAS1 activation. 2005 |
|